- Raised $300k grant, Dec 2023
- Raised $1M funding round, Aug 2022
- Raised $75k grant, Sep 2021
About
ATLASense is addressing healthcare’s most significant and growing challenge: transitioning care from hospitals to homes safely and cost-effectively while preventing life-threatening events. Introducing REPHAEL: the world’s first wearable platform delivering ICU-level monitoring and predictive insights anywhere—hospital, home, or on the go. REPHAEL isn’t just a monitor; it PREDICTS, detects, and alerts healthcare teams to critical risks like respiratory failure, sepsis, heart failure, and falls—days before they escalate. By enabling SAFE, informed clinical decisions remotely ensure hospital-level care at home.
REPHAEL allows ICU-Grade Precision: Continuous, comprehensive monitoring powered by proprietary sensors and AI-driven insights. Its economical advantage: A reusable device that serves multiple patients with various morbidities, offering the lowest cost of use compared to any alternative. Enabling SAFE Decisions: Provides doctors with actionable, predictive data.
Funding history · 6 rounds · $2.8M total
Q&A
- What is ATLASense Biomed's primary focus?
- ATLASense Biomed focuses on providing a wearable solution for clinical decision support, specifically for transitioning patient care from hospitals to homes safely and cost-effectively.
- What is the name of ATLASense Biomed's flagship product?
- ATLASense Biomed's flagship product is REPHAEL, a wearable platform designed for ICU-level monitoring and predictive insights for patients in various settings.
- What capabilities does the REPHAEL platform offer?
- The REPHAEL platform provides continuous, comprehensive monitoring using proprietary sensors and AI-driven insights. It predicts, detects, and alerts healthcare teams to critical risks such as respiratory failure, sepsis, heart failure, and falls.
- When was ATLASense Biomed founded?
- ATLASense Biomed was founded in June 2015.
- What is ATLASense Biomed's current employee count?
- ATLASense Biomed has 11-50 employees.
- What was ATLASense Biomed's most recent funding event?
- ATLASense Biomed received a Grant in December 2023, raising $300,000.
- What is the total amount of funding ATLASense Biomed has raised to date?
- ATLASense Biomed has raised a total of $2,810,000.
- Who are the co-founders of ATLASense Biomed?
- The co-founders of ATLASense Biomed are Dan Atlas, who serves as Co-founder, CTO & Board Member, and Tal Or, who serves as Co-founder & CEO.
- Does ATLASense Biomed hold any patents?
- Yes, ATLASense Biomed holds one patent.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | atlasensebiomed.com |
|---|---|
| linkedin.com/company/16168862 | |
| facebook.com/ATLASense |
Identifiers & details
| Founded | 2015-6 |
|---|---|
| Employees (exact) | 12 |
| Offices | Oak Park |
Radar intelligence
Patents
| EPO | 2 |
|---|
GitHub
| Top repos | gw_installer_v1 |
|---|
Web history (Wayback)
| Domain | atlasensebiomed.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|